☆ 4.2 Article

Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021

JOURNAL OF NEUROENDOCRINOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

Guido Rindi et al.

Summary: In this review, the changes and features of neuroendocrine neoplasms (NENs) in the 2022 WHO Classification of Endocrine and Neuroendocrine Tumors are detailed. The consolidation of nomenclature distinguishing different neoplasms and the importance of Ki67 as a tool for classification and grading are emphasized. The clinical relevance of proper classification and the tools available to pathologists for accurate classification are explained. The article also discusses the differential diagnoses and theranostic biomarkers for NENs, as well as the role of pathologists in identifying precursor lesions and applying molecular immunohistochemistry.

ENDOCRINE PATHOLOGY (2022)

Add to Collection

Article Health Care Sciences & Services

Incidence and survival of neuroendocrine neoplasia in England 1995-2018: A retrospective, population- based study

Benjamin E. White et al.

Summary: The incidence of neuroendocrine neoplasias (NEN) is increasing in England, but survival rates are also improving over time. The relatively high survival rate compared to other cancers poses challenges for long-term outcomes and funding for care.

LANCET REGIONAL HEALTH-EUROPE (2022)

Add to Collection

Article Medicine, General & Internal

Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States

Zihan Xu et al.

Summary: The study analyzed epidemiologic and survival data of 43,751 patients with GEP-NETs from 1975 to 2015, finding a continuous increase in the incidence and prevalence of GEP-NETs, especially among patients with rectal GEP-NETs. Additionally, a nomogram with 5 prognostic parameters was established to accurately quantify the risk of death among patients with GEP-NETs, showing satisfactory clinical practicality.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Endocrinology & Metabolism

Recent Survival Trends in High-Grade Neuroendocrine Neoplasms and Lung Cancer

Lutz Philipp Breitling et al.

NEUROENDOCRINOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade

Arthur Kooyker et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection

Article Oncology

Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015

Yu Jie Zhong et al.

FRONTIERS IN ONCOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Prevalence of Small Intestine Carcinoid Tumors: A US Population-Based Study 2012-2017

Mohannad Abou Saleh et al.

DIGESTIVE DISEASES AND SCIENCES (2019)

Add to Collection

Article Oncology

Survival in neuroendocrine neoplasms; A report from a large Norwegian population-based study

Raziye Boyar Cetinkaya et al.

INTERNATIONAL JOURNAL OF CANCER (2018)

Add to Collection

Article Pathology

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

Guido Rindi et al.

MODERN PATHOLOGY (2018)

Add to Collection

Article Endocrinology & Metabolism

Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010

Raziye Boyar Cetinkaya et al.

NEUROENDOCRINOLOGY (2017)

Add to Collection

Article Oncology

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Arvind Dasari et al.

JAMA ONCOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Trends in diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in India: A report of multicenter data from a web-based registry

Jagannath Palepu et al.

INDIAN JOURNAL OF GASTROENTEROLOGY (2017)

Add to Collection

Article Oncology

Exploring the Rising Incidence of Neuroendocrine Tumors: A Population-Based Analysis of Epidemiology, Metastatic Presentation, and Outcomes

Julie Hallet et al.

CANCER (2015)

Add to Collection

Article Dermatology

Incidence and Survival for Merkel Cell Carcinoma in Queensland, Australia, 1993-2010

Danny R. Youlden et al.

JAMA DERMATOLOGY (2014)

Add to Collection

Article Oncology

Population-Level Analysis of Pancreatic Neuroendocrine Tumors 2 cm or Less in Size

Eric J. Kuo et al.

ANNALS OF SURGICAL ONCOLOGY (2013)

Add to Collection

Article Oncology

Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: Experience of two decades of cancer registry

Catharina M. Korse et al.

EUROPEAN JOURNAL OF CANCER (2013)

Add to Collection

Article Oncology

Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007

B. A. Reichgelt et al.

EUROPEAN JOURNAL OF CANCER (2011)

Add to Collection

Article Gastroenterology & Hepatology

Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan

Tetsuhide Ito et al.

JOURNAL OF GASTROENTEROLOGY (2010)

Add to Collection

Article Oncology

Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

Inger Kristin Larsen et al.

EUROPEAN JOURNAL OF CANCER (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.